TCOT
VRTX icon

Trust Company of Toledo’s Vertex Pharmaceuticals VRTX Stock Holding History

Trust Company of Toledo’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Sell
244
-1
-0.4% -$443 0.01% 344
2026
Q1 		$109K Buy
245
+1
+0.4% +$466 0.01% 350
2025
Q4 		$111K Hold
244
– – 0.01% 332
2025
Q3 		$95.6K Hold
244
– – 0.01% 356
2025
Q2 		$109K Buy
+244
New +$112K 0.01% 326

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Trust Company of Toledo's VRTX Position: Q2 2026 in Review

Trust Company of Toledo reduced its Vertex Pharmaceuticals (VRTX) stake by 0.41% in Q2 2026, selling an estimated $443 and leaving 244 shares worth $121K. The position accounts for 0.01% of the portfolio, ranked #344.

Trust Company of Toledo first reported a position in VRTX in Q2 2025 and has held it in 5 quarters since. 981 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Trust Company of Toledo held 244 shares of Vertex Pharmaceuticals worth $121K as of Q2 2026.
  • Trust Company of Toledo sold 1 Vertex Pharmaceuticals share in Q2 2026, an estimated $443.
  • Vertex Pharmaceuticals made up 0.01% of Trust Company of Toledo's portfolio in Q2 2026, its #344 holding.
  • Trust Company of Toledo first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 981 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.